Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296295655> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W4296295655 abstract "Isotretinoin is among the most frequently used medications in the dermatologic daily practice. With a Black box warning, teratogenicity is a major concern. Female fertility may be an issue to be investigated when it comes to its use in females. The aim of this work was to assess the effect of low dose isotretinoin on the ovarian reserve in female patients with moderate to severe acne. Sixty-sex female acne patients candidate for isotretinoin therapy and 66 controls were enrolled in this prospective controlled cohort study. Low dose isotretinoin (0.25-0.4 mg/kg/day) was given to the patients group for 6 months. Serum anti-Mullarian hormone (AMH), ovarian volume (OV) and Antral follicle count (AFC) were evaluated at baseline and 6 months after the last dose in the patients' group, and 1 year after the baseline assessment for the control subjects. There was no significant difference in serum AMH between patients after isotretinoin treatment and control subjects (p = 0.898). AMH failed to show any significant change in pre- and post- treatment levels in patients' group (p = 0.747). Both OV and AFC showed no significant changes in patient group when comparing pre- post- treatment levels on both sides (p > 0.05) and in control group between baseline and 1-year-interval levels on both sides (p > 0.05). Low-dose isotretinoin in treatment of moderate to severe acne seems to be safer on ovarian reserve as indicated by non-significant change in AMH levels as a sensitive parameter of female fertility." @default.
- W4296295655 created "2022-09-19" @default.
- W4296295655 creator A5012928287 @default.
- W4296295655 creator A5037754398 @default.
- W4296295655 creator A5038594960 @default.
- W4296295655 creator A5063809331 @default.
- W4296295655 creator A5090754151 @default.
- W4296295655 date "2022-09-21" @default.
- W4296295655 modified "2023-09-26" @default.
- W4296295655 title "Systemic isotretinoin for acne treatment: Ovarian reserve is safe with the low dose" @default.
- W4296295655 cites W1971883262 @default.
- W4296295655 cites W1972074673 @default.
- W4296295655 cites W1993017912 @default.
- W4296295655 cites W2010282242 @default.
- W4296295655 cites W2070143210 @default.
- W4296295655 cites W2079644793 @default.
- W4296295655 cites W2094844171 @default.
- W4296295655 cites W2276726626 @default.
- W4296295655 cites W2314090105 @default.
- W4296295655 cites W2337811715 @default.
- W4296295655 cites W2527133569 @default.
- W4296295655 cites W2802781780 @default.
- W4296295655 cites W3047769126 @default.
- W4296295655 cites W3047889783 @default.
- W4296295655 cites W3092028559 @default.
- W4296295655 cites W3098470278 @default.
- W4296295655 cites W2420641995 @default.
- W4296295655 doi "https://doi.org/10.1111/dth.15811" @default.
- W4296295655 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36086943" @default.
- W4296295655 hasPublicationYear "2022" @default.
- W4296295655 type Work @default.
- W4296295655 citedByCount "1" @default.
- W4296295655 countsByYear W42962956552023 @default.
- W4296295655 crossrefType "journal-article" @default.
- W4296295655 hasAuthorship W4296295655A5012928287 @default.
- W4296295655 hasAuthorship W4296295655A5037754398 @default.
- W4296295655 hasAuthorship W4296295655A5038594960 @default.
- W4296295655 hasAuthorship W4296295655A5063809331 @default.
- W4296295655 hasAuthorship W4296295655A5090754151 @default.
- W4296295655 hasConcept C126322002 @default.
- W4296295655 hasConcept C142773365 @default.
- W4296295655 hasConcept C16005928 @default.
- W4296295655 hasConcept C188816634 @default.
- W4296295655 hasConcept C2776285725 @default.
- W4296295655 hasConcept C2776600139 @default.
- W4296295655 hasConcept C2777673923 @default.
- W4296295655 hasConcept C2777688143 @default.
- W4296295655 hasConcept C2779234561 @default.
- W4296295655 hasConcept C29456083 @default.
- W4296295655 hasConcept C42407357 @default.
- W4296295655 hasConcept C54355233 @default.
- W4296295655 hasConcept C71315377 @default.
- W4296295655 hasConcept C71924100 @default.
- W4296295655 hasConcept C86803240 @default.
- W4296295655 hasConceptScore W4296295655C126322002 @default.
- W4296295655 hasConceptScore W4296295655C142773365 @default.
- W4296295655 hasConceptScore W4296295655C16005928 @default.
- W4296295655 hasConceptScore W4296295655C188816634 @default.
- W4296295655 hasConceptScore W4296295655C2776285725 @default.
- W4296295655 hasConceptScore W4296295655C2776600139 @default.
- W4296295655 hasConceptScore W4296295655C2777673923 @default.
- W4296295655 hasConceptScore W4296295655C2777688143 @default.
- W4296295655 hasConceptScore W4296295655C2779234561 @default.
- W4296295655 hasConceptScore W4296295655C29456083 @default.
- W4296295655 hasConceptScore W4296295655C42407357 @default.
- W4296295655 hasConceptScore W4296295655C54355233 @default.
- W4296295655 hasConceptScore W4296295655C71315377 @default.
- W4296295655 hasConceptScore W4296295655C71924100 @default.
- W4296295655 hasConceptScore W4296295655C86803240 @default.
- W4296295655 hasIssue "11" @default.
- W4296295655 hasLocation W42962956551 @default.
- W4296295655 hasLocation W42962956552 @default.
- W4296295655 hasOpenAccess W4296295655 @default.
- W4296295655 hasPrimaryLocation W42962956551 @default.
- W4296295655 hasRelatedWork W1969593162 @default.
- W4296295655 hasRelatedWork W1972074673 @default.
- W4296295655 hasRelatedWork W2010282242 @default.
- W4296295655 hasRelatedWork W2027614408 @default.
- W4296295655 hasRelatedWork W2285307649 @default.
- W4296295655 hasRelatedWork W2314090105 @default.
- W4296295655 hasRelatedWork W2406694545 @default.
- W4296295655 hasRelatedWork W2944531804 @default.
- W4296295655 hasRelatedWork W4296295655 @default.
- W4296295655 hasRelatedWork W2420641995 @default.
- W4296295655 hasVolume "35" @default.
- W4296295655 isParatext "false" @default.
- W4296295655 isRetracted "false" @default.
- W4296295655 workType "article" @default.